Non-hospital consumption of antibiotics in Spain: 1987-1997

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue 3, 2000, Pages 395-400

  Bremón, A Ruiz ^a   Ruiz Tovar, M ^a   Gorricho, B Pérez ^b   De Torres, P Díaz ^c   Rodríguez, R López ^c  

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^c Ministry of Health and Consumer Affairs   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CONSUMER; DRUG DOSE; PRESCRIPTION; SPAIN;

ANTI-BACTERIAL AGENTS; DATABASES, FACTUAL; DRUG UTILIZATION; HUMANS; SPAIN;

EID: 0034052798     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/45.3.395     Document Type: Article

References (28)

1. Ministry of Health, Ministry of Food, Agriculture and Fisheries, Denmark. (1998). The Copenhagen Recommendations. Report from the Invitational EU Conference on the Microbial Threat. Denmark.
2. Levy, S. B. (1991). Antibiotic availability and use: consequences to man and his environment. Journal of Clinical Epidemiology 44, Suppl. II, S83-7.
3. Baquero, F., Martínez Beltrán, J. & Loza, E. (1991). A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. Journal of Antimicrobial Chemotherapy 28, Suppl. C, 31-8.
4. Seppälä, H., Klaukka, T., Lehtonen, R., Nenonen, E. & Huovinen, P. (1995). Outpatient use of erythromycin: link to increased erithromycin resistance in group A streptococci. Clinical Infectious Diseases 21, 1378-85.
5. Arason, V., Kristinsson, K., Sigurdsson, J., Stefansdottir, G., Molstad, S. & Gudmundsson, S. (1996). Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross-sectional prevalence study. British Medical Journal 313, 387-91.
6. Holmberg, S. D., Solomon, S. L. & Blake, P. A. (1987). Health and economic impacts of antimicrobial resistance. Review of Infectious Diseases 9, 1065-78.
7. Dirección General de Salud Pública. (1996). Encuesta Nacional de Salud de España 1995. Ministerio de Sanidad y Consumo, Madrid.
8. Grupo de Trabajo EPINE. (1995). Prevalencia de las infecciones nosocomiales en los hospitales españoles. EPINE 1990-94. Sociedad Española de Higiene y Medicina Preventiva Hospitalaria, Barcelona.
9. Pérez Gorricho, B. (1999). Consumo de antimicrobianos en España. In Antimicrobianos en Medicina, (Prieto Prieto, J., López García, R. & García-Rodríguez, J. A., Eds). Editorial Prous, Madrid, in press.
10. Alós, L. & Carnicero, M. (1997). Consumo de antibióticos y resistencia bacteriana a los antibióticos: algo que te concierne. Medicina Clinica de Barcelona 109, 264-70.
11. Pérez Gorricho, M. B. (1985). Farmacovigilancia de los antibióticos. Estructura de consumo y mecanismos de control. Doctoral Thesis. Universidad Complutense, Madrid.
12. Pérez Gorricho, B. & Baquero, F. (1988). Antibiotic consumption in Spain: The last 10 years. Alliance for the Prudent Use of Antibiotics Newsletter, Spring, 6-7.
13. Baquero, F. (1996). Antibiotic resistance in Spain: what can be done? Task Force of the General Directorate for Health Planning of the Spanish Ministry of Health. Clinical Infectious Diseases 23, 819-23.
14. Col, N. F. & O'Connor, R. W. (1987). Estimating worldwide current antibiotic usage: report of Task Force 1. Review of Infectious Diseases 9, Suppl 3, S232-43.
15. WHO Collaborating Centre for Drug Statistics Methodology. (1993). ATC INDEX, Oslo, Norway.
16. Grupo de Trabajo del SAS para Determinación de DDD. (1996). Dosis diarias definidas y dosis diarias definidas por envases para especialidades farmacéuticas. Junta de Andalucía, Sevilla.
17. Baird, R. (1997). Antibiotic prescribing, controls, and anti-microbial resistance: an Australian experience. Alliance for the Prudent Use of Antibiotics Newsletter 15, 1-2.
18. Davey, P., Bax, R. P., Newey, J., Reeves, D., Rutherford, D., Slack, R. et al. (1996). Growth in the use of antibiotics in the community in England and Scotland in 1980-93. British Medical Journal 312, 613.
19. Frimodt-Moller, N., Espersen, F., Jacobsen, B., Schlundt, J., Meyling, A. & Wegener, H. (1997). Problems with antibiotic resistance in Spain and their relation to antibiotic use in humans elsewhere. Clinical Infectious Diseases 25, 939-41.
20. Viñuales, A., Giráldez, J. & Izue, E. (1993). Análisis de la automedicación VII: perfiles de utilización de los medicamentos. El Farmacéutico 123, 31-40.
21. González, J. & Orero, A. (1996). Consumo de antibióticos en España. Revista Española de Quimioterapia 9, Suppl. 4, 155.
22. Baquero, F., Barrett, J., Courvalin, P., Morrisey, I., Piddock, L. & Novick, W. (1998). Epidemiology and mechanisms of resistance among respiratory tract pathogens. Clinical Microbiology and Infection 4, Suppl. 2, 2S19-2S26.
23. Doern, G. V. (1995). Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract. American Journal of Medicine 99, Suppl. 6B, S3-7.
24. McCaig, L. F. & Hughes, J. M. (1995). Trends in antimicrobial drug prescribing among office-based physicians in the United States. Journal of the American Medical Association 273, 214-19.
25. Llop, J. C. (1997). Evolución de la utilización de antibacterianos en Cataluña. Impacto de los nuevos fármacos comercializados. Atención Primaria 19, 230-6.
26. Belongia, E. & Schwartz, B. (1998). Strategies for promoting judicious use of antibiotics by doctors and patients. British Medical Journal 317, 668-71.
27. Dowell, S., Marcy, S. M., Phillips, W., Gerber, M. & Schwartz, B. (1998). Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections. Pediatrics 101, 163-5.
28. Economic and Social Committee of the European Communities. (1998). Resistance to antibiotics as a threat to public health. EU: Directorate for Communications, Brussels.